The central government fiscal deficit stands at 46.5 per cent of its budget estimates in the first seven months of the current financial year 2025, highlights a report by Union Bank of India.
The agriculture sector is expected to maintain robust growth in the second half of FY25, driven by favorable monsoon conditions, higher reservoir levels, and healthy Rabi sowing, says a report by Bank of Baroda.
The central government's expenditure is projected to grow by around 15 per cent year-on-year (YoY) in the second half of the financial year 2025, with capital expenditure (capex) surging by an impressive 25 per cent YoY, according to a report by Jefferies.
The Reserve Bank of India (RBI) is expected to maintain its policy rate during its upcoming meeting next week, as GDP growth slowed significantly in the second quarter of FY25. However, the likelihood of a rate cut in February has increased, according to a report by HDFC Bank.
India's GDP is expected to fall below 6.5 per cent for the current financial year 2025, as GDP growth in the second quarter (Q2 FY25) slowed to 5.4 per cent, according to a report by the State Bank of India (SBI).
Upasna Bhardwaj, chief economist at Kotak Mahindra Bank, noted that the sharp dip in GDP growth reflects the disappointing corporate earnings data, particularly in the manufacturing sector, which appears to have faced the brunt of the slowdown.
Nifty earnings are expected to witness a modest growth of 5 per cent in FY25, marking the first year of single-digit growth in the past five years, according to a report by Motilal Oswal.
Mumbai (Maharashtra) [India], November 28: Focus Lighting & Fixtures Limited.(NSE - FOCUS), engaged in manufacturing & innovative lighting solutions of LED lights and fixtures, announced its Unaudited Financial Results for Q2 & H1 FY25.
Steel companies in the country are likely to face margin pressure in the third quarter of FY25 as muted steel prices compress spreads, according to a report by Axis Securities.
This upward trend reflects a robust hiring outlook, with 59 per cent of employers planning workforce expansion, 22 per cent maintaining current staffing levels, and only 19 per cent anticipating reductions.
The major pharmaceutical companies of the country reported a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, largely driven by strong performance in North America and the domestic market, according to a report by Axis Securities.
When adjusted for previous period incomes, the TTM EBITDA growth accelerates to a remarkable 34.3 per cent, highlighting the Group's robust operational performance and solid growth trajectory.